Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OSG
2001
Octave Specialty Group
OSG
$243M
| $3.94M | ﹤0.01% |
182,500
+72,200
| +65% | +$1.48M |
|
2002
Extra Space Storage
EXR
$31.3B
| $3.92M | ﹤0.01% |
37,100
-111,700
| -75% | -$12.2M |
|
2003
Riverview Bancorp
RVSB
$107M
| $3.91M | ﹤0.01% |
476,786
+16,369
| +4% | +$123K |
|
|
PTLA
2004
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.9M | ﹤0.01% |
+163,242
| New | +$4.5M |
|
2005
Sonida Senior Living
SNDA
$1.91B
| $3.89M | ﹤0.01% |
84,021
+1,746
| +2% | +$102K |
|
2006
ACNB Corp
ACNB
$656M
| $3.89M | ﹤0.01% |
102,910
+11,400
| +12% | +$402K |
|
|
ITIC
2007
Investors Title Co
ITIC
$546M
| $3.87M | ﹤0.01% |
24,300
+400
| +2% | +$64.7K |
|
|
ZVO
2008
DELISTED
Zovio Inc. Common Stock
ZVO
| $3.85M | ﹤0.01% |
1,869,258
+122,158
| +7% | +$244K |
|
2009
Seres Therapeutics
MCRB
$46.8M
| $3.85M | ﹤0.01% |
55,770
+1,810
| +3% | +$134K |
|
2010
Energizer
ENR
$1.44B
| $3.85M | ﹤0.01% |
+76,600
| New | +$3.52M |
|
2011
Acadia Realty Trust
AKR
$3.09B
| $3.82M | ﹤0.01% |
147,401
+59,159
| +67% | +$1.62M |
|
2012
ITT
ITT
$17.5B
| $3.81M | ﹤0.01% |
51,600
-22,300
| -30% | -$1.48M |
|
2013
Koppers
KOP
$943M
| $3.81M | ﹤0.01% |
99,800
+56,500
| +130% | +$1.98M |
|
2014
EPAM Systems
EPAM
$5.51B
| $3.8M | ﹤0.01% |
+17,900
| New | +$3.52M |
|
|
DL
2015
DELISTED
China Distance Education Holdings Limited
DL
| $3.78M | ﹤0.01% |
467,383
+128,235
| +38% | +$908K |
|
|
AYR
2016
DELISTED
Aircastle Ltd
AYR
| $3.77M | ﹤0.01% |
117,696
-23,604
| -17% | -$682K |
|
2017
StoneX
SNEX
$9.26B
| $3.76M | ﹤0.01% |
389,590
+52,306
| +16% | +$433K |
|
|
AAIC
2018
DELISTED
Arlington Asset Investment Corp.
AAIC
| $3.76M | ﹤0.01% |
674,649
-147,151
| -18% | -$838K |
|
2019
Omega Flex
OFLX
$297M
| $3.75M | ﹤0.01% |
35,000
+8,300
| +31% | +$809K |
|
2020
FB Financial Corp
FBK
$3.02B
| $3.75M | ﹤0.01% |
94,600
-10,600
| -10% | -$406K |
|
2021
Silvercrest Asset Management
SAMG
$79M
| $3.73M | ﹤0.01% |
296,924
+31,900
| +12% | +$402K |
|
|
GPMT
2022
Granite Point Mortgage Trust
GPMT
$69M
| $3.73M | ﹤0.01% |
203,100
-72,421
| -26% | -$1.33M |
|
2023
ADT
ADT
$5.58B
| $3.73M | ﹤0.01% |
+469,800
| New | +$3.71M |
|
|
EMKR
2024
DELISTED
Emcore Corp
EMKR
| $3.72M | ﹤0.01% |
122,457
+3,237
| +3% | +$97.7K |
|
2025
RBB Bancorp
RBB
$448M
| $3.72M | ﹤0.01% |
175,700
+123,500
| +237% | +$2.51M |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.